Short- and Long-Term Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, in the Treatment of Patients with Rheumatoid Arthritis and an Inadequate Response to TNF Inhibitors: Analyses of Pooled Phase 2, Phase 3, and Long-Term Extension Studies.

被引：0
|
作者：
Burmester, G. [1 ]
Blanco, Ricardo [2 ]
Rubbert-Roth, Andrea [3 ]
Hendrikx, Thijs [4 ]
Kwok, Kenneth [5 ]
Bradley, John [6 ]
Zwillich, Samuel H. [6 ]
Benda, Birgitta [7 ]
Mebus, Charles A. [6 ]
机构：
[1] Charite, D-13353 Berlin, Germany
[2] Hosp Univ Marques De Valdecilla, Santander, Spain
[3] Univ Cologne, D-50931 Cologne, Germany
[4] Pfizer Bv, Capelle Aan Den Ijssel, Netherlands
[5] Pfizer Inc, New York, NY USA
[6] Pfizer Inc, Groton, CT 06340 USA
[7] Pfizer Inc, Collegeville, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
L12
引用
收藏
页码：4172 / 4172
页数：1
相关论文
共 50 条
  • [41] Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies
    Marder, Stephen R.
    Hakala, Mika Juhani
    Josiassen, Mette Krog
    Zhang, Peter
    Ouyang, John
    Weiller, Emmanuelle
    Weiss, Catherine
    Hobart, Mary
    ACTA NEUROPSYCHIATRICA, 2017, 29 (05): : 278 - 290
  • [42] TOFACITINIB (CP-690,550), AN ORAL JANUS KINASE INHIBITOR: ANALYSES OF EFFICACY ENDPOINTS BY SUBGROUPS IN A POOLED PHASE 2 AND 3 RHEUMATOID ARTHRITIS STUDY POPULATION
    Kremer, J.
    Zerbini, C.
    Lee, E. B.
    Gruben, D.
    Krishnaswami, S.
    Zwillich, S. H.
    Koncz, T.
    Bradley, J.
    Mebus, C. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 203 - 204
  • [43] Safety and efficacy of tofacitinib, an oral Janus kinase inhibitor, in patients with active psoriatic arthritis: Interim data from OPAL Balance, an open label, long-term extension study
    Nash, Peter
    Coates, Laura C.
    Kivitz, Alan J.
    Mease, Philip J.
    Gladman, Dafna D.
    Covarrubias-Cobos, Jose A.
    Kudlacz, Elizabeth
    Menon, Sujatha
    Kanik, Keith S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB224 - AB224
  • [44] Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study
    Kivitz A.
    Wallace T.
    Olech E.
    Borofsky M.
    Devenport J.
    Pei J.
    Michalska M.
    Rheumatology and Therapy, 2016, 3 (2) : 291 - 304
  • [45] TOFACITINIB, AN ORAL JAK INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND CLINICAL AND RADIOGRAPHIC EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION STUDIES OVER 7 YEARS
    Wollenhaupt, J.
    Silverfield, J.
    Lee, E. B.
    Terry, K. K.
    Kwok, K.
    Lazariciu, I.
    Nduaka, C.
    Connell, C. A.
    DeMasi, R.
    Wang, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 252 - 252
  • [46] Long-Term Antipsychotic Efficacy of Olanzapine and Samidorphan Combination in Patients With Schizophrenia: Pooled Analyses From Phase 3 Studies
    Kahn, Rene
    Graham, Christine
    Jiang, Ying
    DiPetrillo, Lauren
    Bhupathi, Vasudev
    Yagoda, Sergey
    McDonnell, David
    BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S241 - S242
  • [47] Discontinuation of Methotrexate or Glucocorticoids in Patients with Rheumatoid Arthritis Treated with Tofacitinib: Clinical Efficacy Data from Long-Term Extension Studies
    Fleischmann, Roy
    Wollenhaupt, Juergen
    Cohen, Stanley
    Weinblatt, Michael
    Wang, Lisy
    Fan, Haiyun
    Andrews, John
    Takiya, Liza
    Bananis, Eustratios
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [48] Reversibility of pharmacodynamic effects after short and long-term treatment with tofacitinib in patients with rheumatoid arthritis.
    Genovese, Mark C.
    Kawabata, Thomas T.
    Soma, Koshika
    Menon, Sujatha
    Clark, James D.
    Hodge, Jennifer A.
    Takiya, Lisa
    Riese, Richard
    Krishnaswami, Sriram
    PHARMACOTHERAPY, 2014, 34 (10): : E225 - E226
  • [49] Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 8
    Pope, Janet
    Keystone, Edward
    Jamal, Shahin
    Wang, Lisy
    Fallon, Lara
    Woolcott, John
    Lazariciu, Irina
    Haraoui, Boulos
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 879 - 879
  • [50] Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X)
    Weinblatt, Michael E.
    Taylor, Peter C.
    Mcinnes, Iain B.
    Atsumi, Tatsuya
    Strand, Vibeke
    Takeuchi, Tsutomu
    Bracher, Marguerite
    Brooks, David
    Curtis, Paula
    Gupta, Anubha
    Nijhawan, Rina
    O'Shea, Ciara
    Rayner, Kirsty
    Saurigny, Didier
    Shelton, Celia
    Wang, Millie
    Wang, Reena
    Fleischmann, Roy M.
    BMJ OPEN, 2025, 15 (03):
12345